StonvexLoading…
StonvexCore line items from ZUMZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $929.06M | $889.20M | $875.49M | $958.38M |
Operating Income | $17.04M | $1.95M | $-64.79M | $31.10M |
Net Income | $13.38M | $-1.71M | $-62.61M | $21.03M |
EPS (Diluted) | $0.78 | $-0.09 | $-3.25 | $1.08 |
Total Assets | $644.17M | $634.88M | $664.23M | $747.90M |
Total Liabilities | $319.89M | $305.90M | $311.02M | $340.57M |
Cash & Equivalents | $127.86M | $112.67M | $88.88M | $81.50M |
Free Cash Flow OCF − CapEx | $42.41M | $5.70M | $-5.59M | $-26.01M |
Shares Outstanding | 16.97M | 19.16M | 19.83M | 19.49M |